levonorgestrel has been researched along with Thromboembolism in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (10.34) | 18.7374 |
1990's | 14 (48.28) | 18.2507 |
2000's | 6 (20.69) | 29.6817 |
2010's | 5 (17.24) | 24.3611 |
2020's | 1 (3.45) | 2.80 |
Authors | Studies |
---|---|
Bahamondes, L; Brull, EP; Fernandes, A; Juliato, CRT; Monteiro, I | 1 |
Abe, J; Fukuda, A; Hane, Y; Hasegawa, S; Hatahira, H; Hirade, K; Kinosada, Y; Matsui, T; Motooka, Y; Naganuma, M; Nakamura, M; Sasaoka, S; Takahashi, Y | 1 |
Curtis, KM; Dragoman, MV; Gaffield, ME; Tepper, NK | 1 |
Cremer, M; Jacobs, A; Phan-Weston, S | 1 |
Thaler, CJ; Wiegratz, I | 1 |
Ferriani, RA; França, JB; Franceschini, SA; Martins, WP; Vieira, CS | 1 |
Maclennan, AH | 1 |
Ishak, R | 1 |
Ahmad, R; Ang, ES; Gudum, HR; Hassan, K; Ishak, R | 1 |
Jick, H; Jick, SS; Kaye, JA; Russmann, S | 1 |
Brenner, PF; de Quattro, V; Dozono-Takano, R; Eide, I; Gray, G; Mishell, DR; Roy, S; Shaw, ST | 1 |
Gurewich, V; Jick, H; Jick, SS; Myers, MW; Vasilakis, C | 1 |
Taberner, D; Webb, A | 1 |
Lähteenmäki, P | 1 |
Bruppacher, R; Heinemann, LA; Lewis, MA; MacRae, KD; Spitzer, WO | 1 |
Roke, C | 1 |
Lidegaard, O | 1 |
Massil, H; Stirland, AM; Wilkinson, CL | 1 |
Weiss, G | 1 |
Bouma, BN; Büller, HR; Christella, M; Curvers, J; Meijers, JC; Middeldorp, S; Nicolaes, GA; Prins, MH; Rosing, J; Tans, G; Thomassen, LG | 1 |
Jick, H; Jick, SS; Kaye, JA; Vasilakis-Scaramozza, C | 1 |
Meurer, LN; Slawson, JG | 1 |
Dulícek, P | 1 |
Milsom, I; Odlind, V; Ostlund, I; Persson, E; von Schoultz, B | 1 |
Black, C; Jick, H; Kaye, JA | 1 |
Ratnam, SS; Singh, K; Viegas, OA | 1 |
Bonnar, J | 1 |
5 review(s) available for levonorgestrel and Thromboembolism
Article | Year |
---|---|
Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogens; Female; Humans; Levonorgestrel; Norgestrel; Progestins; Risk Factors; Thromboembolism; Venous Thromboembolism; Young Adult | 2017 |
Recent innovations in oral contraception.
Topics: Acne Vulgaris; Androstenes; Contraception; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Estradiol; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperkalemia; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Ovulation; Pregnancy; Randomized Controlled Trials as Topic; Thromboembolism; Uterine Hemorrhage | 2010 |
Postabortal contraception.
Topics: Abortion, Induced; Contraception; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Ovulation; Pregnancy; Risk Factors; Thromboembolism | 1993 |
Update on contraception.
Topics: Breast Neoplasms; Condoms, Female; Contraception; Contraceptives, Oral, Combined; Contraindications; Family Planning Services; Female; Humans; Intrauterine Devices; Levonorgestrel; Patient Education as Topic; Personal Health Services; Thromboembolism | 1997 |
[Hormonal contraception and thromboembolic disease--pathophysiologic findings and practical recommendations].
Topics: Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Female; Hemostasis; Humans; Levonorgestrel; Progestins; Thromboembolism | 2001 |
3 trial(s) available for levonorgestrel and Thromboembolism
Article | Year |
---|---|
Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium.
Topics: Adolescent; Adult; Blood Pressure; Brachial Artery; Brazil; Carotid Artery, Common; Carotid Intima-Media Thickness; Chlormadinone Acetate; Contraceptives, Oral, Combined; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Longitudinal Studies; Progestins; Risk; Thromboembolism; Vascular Stiffness; Vasoconstriction; Vasoconstrictor Agents; Young Adult | 2013 |
Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Topics: Adolescent; Adult; Alkaline Phosphatase; Angiotensin II; Antithrombin III; Aspartate Aminotransferases; Bilirubin; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Levonorgestrel; Mestranol; Norethindrone; Norgestrel; Thromboembolism; Transcortin; Triglycerides | 1980 |
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
Topics: Activated Protein C Resistance; Adolescent; Adult; Contraceptives, Oral, Synthetic; Cross-Over Studies; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Protein C; Risk Factors; Thrombin; Thromboembolism | 1999 |
21 other study(ies) available for levonorgestrel and Thromboembolism
Article | Year |
---|---|
Safety and bleeding patterns of the levonorgestrel 52-mg intrauterine system among women with thrombosis or coagulopathy.
Topics: Adult; Amenorrhea; Anticoagulants; Blood Coagulation Disorders; Brazil; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Oligomenorrhea; Retrospective Studies; Thromboembolism; Thrombosis | 2020 |
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Androstenes; Child; Contraceptives, Oral, Combined; Databases, Factual; Desogestrel; Drug-Related Side Effects and Adverse Reactions; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Levonorgestrel; Male; Middle Aged; Norethindrone; Norgestrel; Odds Ratio; Progestins; Thromboembolism; Young Adult | 2017 |
Hormonal contraception--what kind, when, and for whom?
Topics: Cardiovascular Diseases; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Implants; Drug-Related Side Effects and Adverse Reactions; Female; Germany; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Papillomavirus Infections; Pregnancy; Pregnancy, Unwanted; Progesterone Congeners; Risk Factors; Thromboembolism; Uterine Cervical Neoplasms | 2011 |
Oral contraceptives.
Topics: Age Factors; Behavior; Biology; Breast Feeding; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Demography; Disease; Embolism; Endocrine System; Ethinyl Estradiol; Family Planning Services; Health; Heart Diseases; Hormones; Hypertension; Infant Nutritional Physiological Phenomena; Levonorgestrel; Liver Diseases; Mestranol; Morbidity; Mortality; Norethindrone; Nutritional Physiological Phenomena; Physiology; Population; Population Characteristics; Population Dynamics; Progesterone; Progestins; Smoking; Thromboembolism; Vascular Diseases | 1987 |
Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Case-Control Studies; Clinical Laboratory Techniques; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Desogestrel; Developing Countries; Diagnosis; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hematocrit; Hematologic Tests; Levonorgestrel; Malaysia; Methods; Physiology; Research; Research Design; Thromboembolism; Thrombosis; Vascular Diseases | 1991 |
Pill research results in new guidance from CSM.
Topics: Biology; Communication; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Demography; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Geography; Health; Health Personnel; Knowledge; Levonorgestrel; Norethindrone; Population; Public Health; Residence Characteristics; Risk Assessment; Risk Factors; Safety; Thromboembolism; Thrombosis; United Kingdom; Vascular Diseases | 1995 |
Fibrinolytic response in women on low-dose oral contraceptive.
Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Clinical Laboratory Techniques; Clinical Trials as Topic; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Developing Countries; Diagnosis; Disease; Embolism; Family Planning Services; Fibrinolysis; Hematologic Tests; Levonorgestrel; Malaysia; Physiology; Research; Thromboembolism; Thrombosis; Vascular Diseases | 1992 |
Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Databases, Factual; Desogestrel; Female; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Odds Ratio; Risk Factors; Thromboembolism | 2006 |
Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Topics: Adult; Age Factors; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Progesterone Congeners; Progestins; Risk Factors; Smoking; Thromboembolism; Time Factors | 1995 |
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Thromboembolism | 1995 |
Clotting factors after emergency contraception.
Topics: Administration, Oral; Adolescent; Adult; Antithrombin III; Contraceptives, Oral, Combined; Contraindications; Emergencies; Ethinyl Estradiol; Factor VII; Female; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Risk Factors; Thromboembolism; Time Factors | 1993 |
The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.
Topics: Adolescent; Adult; Bias; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Progesterone Congeners; Risk Factors; Thromboembolism | 1996 |
Oral contraception and venous thromboembolism. A New Zealand perspective.
Topics: Bias; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; New Zealand; Odds Ratio; Risk Factors; Thromboembolism | 1997 |
The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Causality; Contraceptives, Oral; Denmark; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Migraine Disorders; Multivariate Analysis; Norgestrel; Norpregnenes; Risk Factors; Smoking; Socioeconomic Factors; Thromboembolism | 1997 |
Risk of venous thromboembolism with third-generation oral contraceptives: A review.
Topics: Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Risk Factors; Thromboembolism; Venous Thrombosis | 1999 |
Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis.
Topics: Adolescent; Adult; Age Distribution; Body Mass Index; Case-Control Studies; Cohort Studies; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Odds Ratio; Risk Factors; Smoking; Thromboembolism; Time Factors | 2000 |
What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Humans; Levonorgestrel; Norpregnenes; Progesterone Congeners; Risk Factors; Thromboembolism; Venous Thrombosis | 2001 |
[Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations].
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Contraindications; Desogestrel; Drug Information Services; Drug Prescriptions; Female; Humans; Levonorgestrel; Practice Guidelines as Topic; Progestins; Risk Factors; Thromboembolism; Venous Thrombosis | 2002 |
Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Odds Ratio; Risk Factors; Thromboembolism; Venous Thrombosis | 2002 |
A three-year evaluation of hemostatic function in Singaporean Norplant-2 rod acceptors.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Hemostasis; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Partial Thromboplastin Time; Prothrombin Time; Singapore; Thromboembolism | 1990 |
Coagulation effects of oral contraception.
Topics: Blood Coagulation; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes; Platelet Aggregation; Risk Factors; Thromboembolism; Thrombosis | 1987 |